Skip to main content

Pulmonx Corp

For the period ended Dec 31, 2023. Filed Feb 27, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 27, 2024

LUNG$2.80+9.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Redwood City, State of California, on the 27th day of February, 2024.

PULMONX CORPORATION
By:/s/ Glendon E. French
Glendon E. French
President, Chief Executive Officer and Director
By:/s/ John McKune
John McKune
Interim Chief Financial Officer

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Glendon E. French and John McKune, jointly and severally, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place, and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming that all said attorneys-in-fact and agents, or his or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated:

SignatureTitleDate
/s/ Glendon E. FrenchPresident, Chief Executive Officer and DirectorFebruary 27, 2024
Glendon E. French(Principal Executive Officer)
/s/ John McKuneInterim Chief Financial OfficerFebruary 27, 2024
John McKune(Principal Financial Officer and Principal Accounting Officer)
/s/ Thomas W. BurnsDirectorFebruary 27, 2024
Thomas W. Burns
/s/ Richard FerrariDirectorFebruary 27, 2024
Richard Ferrari
/s/ Daniel P. FlorinDirectorFebruary 27, 2024
Daniel P. Florin
/s/ Georgia Garinois-MelenikiotouDirectorFebruary 27, 2024
Georgia Garinois-Melenikiotou
/s/ Alissa Hsu LynchDirectorFebruary 27, 2024
Alissa Hsu Lynch
/s/ Dana G. Mead, Jr.DirectorFebruary 27, 2024
Dana G. Mead, Jr.
/s/ Tiffany SullivanDirectorFebruary 27, 2024
Tiffany Sullivan
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.